Drugs / APOSEC™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02284360 | Oct 2014 → Jun 2015 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APOSEC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02284360 ↗ |
| Modality | Protein / enzyme biologic | “the cytokine based gel APOSEC™” NCT02284360 ↗ |
| Route | Topical | “APOSEC™ is intended for topical use only” NCT02284360 ↗ |